Fig. 1
From: Molecular docking and pharmacokinetics of benzimidazole-based FtsZ inhibitors for tuberculosis
Biologically active compounds having Benzimidazole Moiety.
Fig. 1 | Scientific Reports
From: Molecular docking and pharmacokinetics of benzimidazole-based FtsZ inhibitors for tuberculosis
Biologically active compounds having Benzimidazole Moiety.
